MKI67 and prostate neoplasm: As shown in Fig. 6d–h, tumors with overexpressed miR-190a had reduced expression of AR, YB-1 and Ki-67, and increased CDKN1A, suggesting that overexpression of miR-190a inhibited prostate tumor growth in vivo.